NCT06060912View on ClinicalTrials.gov

LAmbre Versus AMPLATZER Amulet Left AtrIal Appendage Occluder for StRoke ProphylaxIs

NARecruitingINTERVENTIONAL
Enrollment

226

Participants

Timeline

Start Date

December 5, 2023

Primary Completion Date

January 15, 2026

Study Completion Date

October 15, 2027

Conditions
Left Atrial Appendage Occlusion
Interventions
DEVICE

Left Atrial Appendage Occlusion

Left Atrial Appendage Occlusion will be performed according to current international standards by experienced operators under TOE and angiographic guidance. Either a LAmbre occlusion device (group A) or an AMPLATZER Amulet occlusion device (group B) will be implanted depending on treatment allocation.

Trial Locations (1)

80636

RECRUITING

Klinik für Herz- und Kreislauferkrankungen, Deutsches Herzzentrum München, Technische Universität München, Munich

All Listed Sponsors
collaborator

Lifetech Scientific (Shenzhen) Co., Ltd.

INDUSTRY

lead

Deutsches Herzzentrum Muenchen

OTHER